Pathos
Pathos is a clinical-stage, AI-enabled precision oncology biotech. We’re building the next generation of biopharma, where drug development is driven by AI and Multimodal patient data, not guesswork. With the largest Multimodal Foundation Model in Oncology as a backbone, we're running an integrated engine that pairs model-driven hypotheses with biological validation and biomarker-driven clinical execution, so the right therapies reach the right patients sooner.www.pathos.com
1
MENTIONS
1
EPISODES
1
PODCASTS
Search complete. 1 mention across 1 episode found for "Pathos".
Oct 2, 2026
Eleanor HoweHOST
Since then, he's co-founded Sage Bionetworks, served as chief scientific officer at Pacific Biosciences, built the Icon Institute for Genomics and Multiscale Biology at Mount Sinai, where he is still dean for precision medicine, and founded the genomics company Sema4 and took it public.
Eleanor HoweHOST
Most recently, he was chief science officer at Pathos AI, working on one of the largest multimodal foundational models built in oncology.
Eleanor HoweHOST
And a few weeks ago, he joined Pfizer's R&D organization as their first AI scholar and started a new company that's still in stealth.
Eleanor HoweHOST
Eric, welcome to The Trenches.